Emerging Data May Provide More Options for Systemic Treatment of Basal Cell Carcinoma, Says InNovember 12th 2020
During a Targeted Oncology Case Based Peer Perspective event, Gino K. In, MD, MPH, assessed the risk status of an 88-year-old patient with basal cell carcinoma and discussed treatment options.
Pennell Considers Treatments in Front- and Later-Line Settings for EGFR+ NSCLCNovember 8th 2020
In the treatment of EGFR-mutant non–small cell lung cancer, oncologists face multiple challenges with prescribing medications to patients. During a Targeted Oncology Case Based Peer Perspective event, Nathan Pennell, MD, PhD, discussed these challenges as well as potential treatment approaches with a group of peers.
Kulik Addresses Transplant and Therapy in HCCNovember 6th 2020
Laura M. Kulik, MD, talked through diagnosing a 77-year-old female patients with hepatocellular carcinoma as well as the treatment options for her disease during a Targeted Oncology Case Based Peer Perspectives event.
Aggarwal Examines Nivolumab Plus Ipilimumab in First-Line NSCLCNovember 5th 2020
The use of chemoimmunotherapy as treatment of patients with treatment-naive stage IIIB or IV nonsquamous non–small cell lung cancer was the topic of a Targeted Oncology Case Based Peer Perspective discussion led by Charu Aggarwal, MD, MPH.
Leal Discusses Therapy Selection in Oncogene-Driven Lung CancerNovember 4th 2020
A selection of therapies exist for patients with oncogene-driven lung cancer. Ticiana Leal, MD, discussed these options with a group of peers during a Targeted Oncology Case Based Peer Perspectives event.
Heymach Discusses MET Exon 14 Skipping Mutations in NSCLCNovember 3rd 2020
During a Targeted Oncology Case Based Peer Perspective event, John V. Heymach, MD, PhD, discussed the testing methods for non–small cell lung cancer with MET exon 14 skipping mutations. The discussion was based on the case of a 48-year-old woman.
Brander Details Different Therapies and Modalities for Treatment of CLL in the Second LineOctober 29th 2020
During a Targeted Oncology Case Based Peer Perspectives event, Danielle Brander, MD, assistant professor of Medicine at Duke Cancer Institute in Durham, NC, discussed options for treating a 53-year-old female patients with chronic lymphocytic leukemia.